Novo Nordisk A/S (NVO)

Novo Nordisk Revenue

Novo Nordisk had revenue of $35.35B in the twelve months ending March 31, 2024, with 28.21% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $9.46B with 21.03% year-over-year growth. In the year 2023, Novo Nordisk had annual revenue of $34.41B with 34.95% growth.

• Revenue (ttm): $35.35B
• Revenue Growth: +28.21%
• P/S Ratio: 17.78
• Revenue / Employee: $549,547
• Employees: 64,319
• Market Cap: 628.28B USD

Revenue Chart

* The company reports in DKK currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	34.41B	8.91B	34.95%
Dec 31, 2022	25.50B	4.16B	19.52%
Dec 31, 2021	21.33B	522.51M	2.51%
Dec 31, 2020	20.81B	2.60B	14.27%
Dec 31, 2019	18.21B	1.06B	6.18%
Dec 31, 2018	17.15B	-856.52M	-4.76%
Dec 31, 2017	18.01B	2.19B	13.82%
Dec 31, 2016	15.82B	-1.40B	-8.13%
Dec 31, 2015	17.22B	2.91B	20.31%
Dec 31, 2014	14.32B	-1.30B	-8.35%
Dec 31, 2013	15.62B	1.04B	7.11%
Dec 31, 2012	14.58B	2.18B	17.60%
Dec 31, 2011	12.40B	1.04B	9.16%
Dec 31, 2010	11.36B	1.81B	18.99%
Dec 31, 2009	9.55B	1.03B	12.13%
Dec 31, 2008	8.51B	695.70M	8.90%
Dec 31, 2007	7.82B	577.20M	7.97%
Dec 31, 2006	7.24B	871.87M	13.69%
Dec 31, 2005	6.37B	861.08M	15.63%
Dec 31, 2004	5.51B	1.12B	25.51%
Dec 31, 2003	4.39B	886.67M	25.32%
Dec 31, 2002	3.50B	153.52M	4.58%
Dec 31, 2001	3.35B	417.61M	14.25%
Dec 31, 2000	2.93B	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.